Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
21:06:13 EST Fri 23 Jan 2026
Enter Symbol
or Name
USA
CA



Q:YDES - YD BIO LTD - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
YDES - Q0.110.29·14.380.112.36+0.060.511.813417112.33  12.50  11.970225.00  7.2017:50:17Jan 0615 min RT 2¢

Recent Trades - Last 10 of 171
Time ETExPriceChangeVolume
17:50:17Q12.01-0.2925
17:36:08Q12.01-0.2938
17:13:23Q12.01-0.293
16:10:05Q12.245-0.0551
16:00:01Q12.245-0.0552
16:00:01Q12.245-0.05515
16:00:01Q12.245-0.0557
16:00:00Q12.245-0.05574
15:59:55Q12.245-0.0552
15:59:54Q12.350.05100

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-01-06 09:00U:YDESNews ReleaseYD Bio Enters into MOU to Merge with EG BioMed, Advancing DNA Methylation-Driven AI Platforms for Cancer Diagnostics and Drug Development
2026-01-05 09:00U:YDESNews ReleaseYD Bio Limited Announces Major Milestones and Unveils Robust 2026 Clinical and Commercial Roadmap
2025-12-16 09:00U:YDESNews ReleaseYD Bio Limited Expands U.S. Presence with Newly Planned California Facilities and Operations Center
2025-12-09 09:00U:YDESNews ReleaseYD Bio Limited Showcases Its Innovative Diagnostic and Precision Medicine Portfolios at the 9th Healthcare EXPO TAIWAN
2025-12-02 09:00U:YDESNews ReleaseYD Bio Limited Expands OkaiDx(TM) Testing Portfolio to Pancreatic and Colorectal Cancer Detection Across the U.S. and Provides Clinical Research Update on Pancreatic Cancer Early Detection
2025-11-24 09:00U:YDESNews ReleaseYD Bio Limited Announces U.S. Ophthalmology Market Entry, Advances Across Diagnostics and LSC Exosome Therapeutics
2025-11-05 08:30U:YDESNews ReleaseYD Bio and EG BioMed Expand U.S. Access to OkaiDx(TM), a cfDNA-Methylation Blood Test for Post-Treatment Breast Cancer Monitoring
2025-10-20 10:20U:YDESNews ReleaseYD Bio Ltd. Rings Nasdaq Opening Bell to Celebrate Listing under Ticker YDES
2025-10-10 08:37U:YDESNews ReleaseYD Bio Business Partner EG Biomed Achieves CAP Accreditation, Advancing U.S. Clinical Testing Capabilities
2025-09-30 17:25U:YDESNews ReleaseYD Bio Limited Reports Unaudited Half Year 2025 Financial Results
2025-08-29 07:30U:YDESNews ReleaseYD Bio Limited Announces Closing of Business Combination and Listing on the Nasdaq Global Market
2025-08-28 14:33U:YDESNews ReleaseYD Bio Limited Announces Closing of Business Combination and Listing on the Nasdaq Global Market